Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal transit modulation describes the alteration of the rate or pattern of movement of food and waste through the digestive tract. This process is regulated by complex interactions between the enteric nervous system, central autonomic circuits, interstitial cells of Cajal, gut peptides (such as cholecystokinin, glucagon-like peptide-1, peptide YY, ghrelin), and the intestinal microbiota. Drugs targeting these systems can either accelerate or slow gut transit to treat conditions like constipation, diarrhea, and disorders of nutrient absorption. Gastrointestinal transit is not a specific gene or protein, but a physiological process governed by multiple integrated molecular and cellular pathways.
Modulation of neural (enteric and autonomic nervous system) signaling, Hormonal regulation (e.g., via GLP-1, CCK, PYY), Direct effects on smooth muscle contractility, Modulation of interstitial cells of Cajal activity, Altering gut microbiota composition
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal transit modulation.